Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential Esketamine Dosages for Postoperative Anxiety and Depression After Gynecological Laparoscopy
ChiCTR2500110758Phase 4Recruiting
- Sponsor
- Dandong First Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Perioperative anxiety, major depressive disorder (MDD) and postoperative pain (4 arms), sponsored by Dandong First Hospital. Primary endpoint: Changes in Hospital Anxiety and Depression Scale (HADS) scores. Started Oct 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
Perioperative anxietymajor depressive disorder (MDD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500110758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110758.